PL2046312T3 - Produkty farmaceutyczne i nutraceutyki zawierające witaminę K2 - Google Patents

Produkty farmaceutyczne i nutraceutyki zawierające witaminę K2

Info

Publication number
PL2046312T3
PL2046312T3 PL07765188T PL07765188T PL2046312T3 PL 2046312 T3 PL2046312 T3 PL 2046312T3 PL 07765188 T PL07765188 T PL 07765188T PL 07765188 T PL07765188 T PL 07765188T PL 2046312 T3 PL2046312 T3 PL 2046312T3
Authority
PL
Poland
Prior art keywords
vitamin
pharmaceutical
nutraceutical products
nutraceutical
products
Prior art date
Application number
PL07765188T
Other languages
English (en)
Inventor
Cees Vermeer
Leon J. Schurgers
Jo Klaveness
Hogne Vik
Anne Bjornebye Vik
Stein Westbye
Original Assignee
Kaydence Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38820269&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2046312(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kaydence Pharma As filed Critical Kaydence Pharma As
Publication of PL2046312T3 publication Critical patent/PL2046312T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/60Fish, e.g. seahorses; Fish eggs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15Vitamins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/04Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Vascular Medicine (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Medicinal Preparation (AREA)
PL07765188T 2006-07-14 2007-07-13 Produkty farmaceutyczne i nutraceutyki zawierające witaminę K2 PL2046312T3 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
NO20063292 2006-07-14
NO20063291 2006-07-14
NO20063988 2006-09-06
PCT/EP2007/006241 WO2008006607A2 (en) 2006-07-14 2007-07-13 Pharmaceutical and nutraceutical products comprising vitamin k2
EP07765188.3A EP2046312B1 (en) 2006-07-14 2007-07-13 Pharmaceutical and nutraceutical products comprising vitamin k2

Publications (1)

Publication Number Publication Date
PL2046312T3 true PL2046312T3 (pl) 2021-02-08

Family

ID=38820269

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07765188T PL2046312T3 (pl) 2006-07-14 2007-07-13 Produkty farmaceutyczne i nutraceutyki zawierające witaminę K2

Country Status (10)

Country Link
US (1) US20100048704A1 (pl)
EP (1) EP2046312B1 (pl)
JP (2) JP5827784B2 (pl)
AU (1) AU2007271900B2 (pl)
CA (1) CA2657748C (pl)
ES (1) ES2790590T3 (pl)
NO (1) NO343923B1 (pl)
NZ (1) NZ574882A (pl)
PL (1) PL2046312T3 (pl)
WO (1) WO2008006607A2 (pl)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2144618E (pt) 2007-03-28 2013-07-08 Aker Biomarine Asa Composições bioeficazes de óleo de krill
US8697138B2 (en) 2007-03-28 2014-04-15 Aker Biomarine As Methods of using krill oil to treat risk factors for cardiovascular, metabolic, and inflammatory disorders
US8343753B2 (en) 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
NL1034964C2 (nl) * 2008-01-28 2009-07-30 Friesland Brands Bv Werkwijze en composities voor de behandeling van botaandoeningen.
GB0817701D0 (en) * 2008-09-26 2008-11-05 Omegatri As Krill oil powder and krill oil tablets
US8372812B2 (en) 2009-02-26 2013-02-12 Aker Biomarine Asa Phospholipid and protein tablets
FR2949044B1 (fr) * 2009-08-12 2021-05-07 Expanscience Lab Composition comprenant une fraction d'insaponifiable
JP2013504571A (ja) * 2009-09-14 2013-02-07 ネステク ソシエテ アノニム 外因性ビタミンk2を含む栄養組成物
GB2476644B (en) 2009-12-23 2012-11-14 Haomamedica Ltd 1,4-Dihydro-1,4-dioxonaphtalene derivatives for the treatment of osteoporosis
JP2013538799A (ja) * 2010-08-06 2013-10-17 アンペア ライフ サイエンシーズ,インコーポレイテッド ビタミンkを用いたミトコンドリア病の処置
AU2011324792A1 (en) * 2010-11-01 2013-05-30 Viridis Biopharma Pvt. Ltd Dynamic balancing of autonomic nervous system through vitamin MK-7
NL2008294C2 (en) * 2011-05-20 2013-08-19 Friesland Brands Bv Food composition comprising vitamin k and saturated fat.
RU2606767C2 (ru) * 2011-05-20 2017-01-10 Фрисланд Брандз Б.В. Композиция, содержащая витамин k2
AU2014203179C1 (en) 2013-06-14 2017-05-04 Aker Biomarine Antarctic As Lipid extraction processes
EP2886129A1 (en) 2013-12-20 2015-06-24 VitaK B.V. Prevention and counteraction of diet-induced thrombosis risk
GB201400431D0 (en) 2014-01-10 2014-02-26 Aker Biomarine As Phospholipid compositions and their preparation
AU2016217559A1 (en) 2015-02-11 2017-08-31 Aker Biomarine Antarctic As Lipid extraction processes
NZ747847A (en) 2015-02-11 2023-06-30 Aker Biomarine Antarctic As Lipid compositions
EP3359130A4 (en) 2015-10-09 2019-05-01 Combocap, Inc. CAPSULE WITH VOLUME ADJUSTABLE INTERNAL MEMBRANE
US11911349B2 (en) 2018-03-30 2024-02-27 Nattopharma As Rapidly improving vascular conditions by administering vitamin K
WO2019237054A1 (en) * 2018-06-08 2019-12-12 Epizon Pharma, Inc. Methods and compositions for preventing or treating calciphylaxis
WO2019237053A1 (en) 2018-06-08 2019-12-12 Epizon Pharma, Inc. Methods and compositions for preventing or treating tissue calcification
WO2021165859A1 (en) * 2020-02-19 2021-08-26 Yogesh Dound A composition comprising vitamin k2-7 in combination with vitamin k-1 in purest form

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1176916B (it) * 1984-10-10 1987-08-18 Elvira Pistolesi Composizione farmaceutica o dietetica ad elevata attivita' antitrombotica e antiarteriosclerotica
JP2577584B2 (ja) * 1987-11-13 1997-02-05 雪印乳業株式会社 多価不飽和脂肪酸とビタミンaを含有する組成物の保存方法
US5180747A (en) * 1989-02-28 1993-01-19 Nisshin Flour Milling Co., Ltd. Stabilized fat-soluble vitamin compositions
JPH03254658A (ja) * 1990-03-01 1991-11-13 Binshiyoo:Kk 納豆によるスナック食品の製造法
JPH04253908A (ja) * 1990-12-28 1992-09-09 Nippon Oil & Fats Co Ltd 骨粗鬆症治療薬
JP3092180B2 (ja) * 1991-02-27 2000-09-25 日本油脂株式会社 低密度リポ蛋白受容体活性化剤
IT1274734B (it) * 1994-08-25 1997-07-24 Prospa Bv Composizioni farmaceutiche contenenti acidi grassi poliinsaturi, loro esteri o sali, unitamente a vitamine o provitamine antiossidanti
GB9713620D0 (en) 1997-06-28 1997-09-03 Boots Co Plc Composition
GB9901809D0 (en) * 1999-01-27 1999-03-17 Scarista Limited Highly purified ethgyl epa and other epa derivatives for psychiatric and neurological disorderes
US7226916B1 (en) * 2000-05-08 2007-06-05 N.V. Nutricia Preparation for the prevention and/or treatment of vascular disorders
DK1153548T3 (da) * 2000-05-12 2007-09-10 Nattopharma Asa Levnedsmiddelprodukt, der indeholder vitamin k2
GB0016452D0 (en) * 2000-07-04 2000-08-23 Kilgowan Limited Vitamin K and essential fatty acids
EP1370257B1 (en) * 2001-03-15 2007-07-25 DSM IP Assets B.V. COMPOSITION FOR THE PREVENTION OF OSTEOPOROSIS consisting of A COMBINATION OF ISOFLAVONES AND POLYUNSATURATED FATTY ACIDS
DK1406641T3 (da) * 2001-06-18 2009-05-04 Neptune Technologies & Bioress Krillekstrakter til forebyggelse og/eller behandling af cardiovaskulære sygdomme
EP1455725B1 (en) * 2001-10-09 2006-08-02 Research Foundation of Suny Apparatus for treating orthostatic hypotension
JP2003169632A (ja) * 2001-12-08 2003-06-17 Sapuri:Kk 米胚芽油、卵黄油及びホスファチジルセリン含有の健康食品
JP2003313142A (ja) * 2002-02-20 2003-11-06 En Otsuka Pharmaceutical Co Ltd 栄養組成物
JP3999532B2 (ja) * 2002-02-26 2007-10-31 三菱重工業株式会社 輸送用冷凍装置
GB0210212D0 (en) * 2002-05-03 2002-06-12 Univ Southampton Effects of dietary N-3 and N-6 pufa intake on atheromatous plaque stability
GB0220182D0 (en) * 2002-08-30 2002-10-09 Cardiovascular Res Inst Maastr Organic compounds
WO2005030190A1 (en) * 2003-09-26 2005-04-07 Natural Asa Natural menaquinone 7 compositions
JP2005237300A (ja) * 2004-02-26 2005-09-08 Aichi Prefecture 食品素材及びその製造方法

Also Published As

Publication number Publication date
ES2790590T3 (es) 2020-10-28
NO343923B1 (no) 2019-07-08
JP5827784B2 (ja) 2015-12-02
CA2657748C (en) 2014-10-21
WO2008006607A3 (en) 2008-10-23
CA2657748A1 (en) 2008-01-17
AU2007271900A1 (en) 2008-01-17
AU2007271900B2 (en) 2013-05-23
JP2009544590A (ja) 2009-12-17
EP2046312A2 (en) 2009-04-15
NO20090692L (no) 2009-04-01
EP2046312B1 (en) 2020-02-19
NZ574882A (en) 2012-08-31
US20100048704A1 (en) 2010-02-25
JP2014031378A (ja) 2014-02-20
WO2008006607A2 (en) 2008-01-17

Similar Documents

Publication Publication Date Title
PL2046312T3 (pl) Produkty farmaceutyczne i nutraceutyki zawierające witaminę K2
IL275854A (en) Pharmaceutical composition and its administration
IL242883B (en) Aryl-amino and heteroaryl-amino converted deoxazolines and pharmaceutical preparations containing them
IL217916A0 (en) Pharmaceutical products
GB0803072D0 (en) Solid pharmaceutical and vaccien dose
IL194546A0 (en) Arylaminopyridine derivatives and pharmaceutical compositions containing them
EP2018872A4 (en) PHARMACEUTICAL PRODUCT
IL214911A0 (en) Solfonylated tetrahydroazolopyrazines and their use as medicinal products
ZA200901464B (en) Packaging comprising pharmaceutical forms
HK1125295A1 (en) Microtablet-based pharmaceutical preparation
IL194751A0 (en) Drugs and uses
EP2135074A4 (en) PHARMACEUTICAL PLATFORM TECHNOLOGY FOR THE DEVELOPMENT OF NATURAL PRODUCTS
IL197107A0 (en) Pharmaceutical compositions including vitamin d and corticosteriod
ZA200900423B (en) Methods and medicaments for administration of ibuprofen
IL197877A (en) Uses of aminomethyl-4-imidazole derivatives for the preparation of medications and medications containing them
PL2173195T3 (pl) Biomasa wzbogacona w cynk, sposób jej wytwarzania oraz zawierające ją produkty probiotyczne, kosmetyczne, dietetyczne i nutraceutyczne
GB0614586D0 (en) Pharmaceutical Formulation
IL193211A (en) Derivatives of Indzol-Troaril and pharmaceutical preparations containing them
IL183178A (en) Pharmaceutical products containing at least three solid tablets and methods for making them
HK1177695A1 (en) Pharmaceutical composition comprising vitamin d analogue and cosolvent- surfactant mixture d-
IL197273A0 (en) Pharmaceutical and sunscreen compositions comprising caspase-14
ZA201101752B (en) A medicinal product and treatment
GB0614365D0 (en) Pharmaceutical compositions and their use
EP2322505A4 (en) 1-ADAMANTYLAZETIDIN-2-ON DERIVATIVE, PREPARATION THEREOF AND PHARMACEUTICAL PREPARATION THEREWITH
IL195822A0 (en) Segmented pharmaceutical dosage forms